FOA-Special Exception
to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic; June 9,
2020
Notice
Number:
NOT-OD-20-123
Release
Date:
June
9, 2020
NOT-OD-19-083 -
Update to the NIH/AHRQ/NIOSH Policy on Post-Submission
Materials
NOT-OD-20-086 -
Flexibilities Available to Applicants and Recipients of Federal Financial
Assistance Affected by COVID-19
NATIONAL
INSTITUTES OF HEALTH (NIH)
Agency for Healthcare Research and Quality ( AHRQ )
The National Institute for Occupational Safety and Health ( NIOSH)
The
NIH, AHRQ, and NIOSH understand that the emergency declaration related to
Coronavirus Disease 2019 (COVID-19) will adversely affect the ability of many
applicants to generate preliminary data in time for their grant applications
submitted for the current due dates (for January 2021 Council beginning with
applications submitted for the May 25, 2020 due date). However, with
implementation of the President's
Guidelines for Re-Opening America Again,
NIH, AHRQ, and NIOSH anticipate that many investigators may be able to generate
preliminary data for those applications before peer review. Therefore, this
Notice provides an exception to the NIH/AHRQ/NIOSH policy for post-submission
materials (NOT-OD-19-083).
For
applications submitted for the January 2021 council (beginning with applications
submitted for the May 25, 2020 due date for Fall 2020 review meetings), the NIH,
AHRQ, and NIOSH will accept a one-page update with preliminary data as
post-submission materials for applications submitted under all activity codes,
ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed
preliminary data in the application. One page of preliminary data will be
accepted for single component applications or for each component of a
multi-component application.
The
deadline for submitting all post-submission materials, including preliminary
data, will be 30 days before the study section meeting. Because applications
for emergency competitive revisions and urgent competitive revisions undergo
expedited review, post-submission materials will not be accepted for those
applications.
All
other materials listed in NOT-OD-19-083 as
acceptable post-submission materials will continue to be accepted if submitted
30 days before the study section meeting.
Please
direct all inquiries to:
Sally
A. Amero, Ph.D.
NIH
Review Policy Officer
ReviewPolicyOfficer@mail.nih.gov
Francis
D. Chesley, Jr., M.D.
Agency for Healthcare Research and Quality
Telephone: 301-427-1521
Email:Francis.Chesley@ahrq.hhs.gov
Steve
Dearwent, Ph.D.
Centers for Disease Control and Prevention
Telephone: 404-498-6382
Email:Sed7@cdc.gov
Michael
Goldcamp, Ph.D.
Centers for Disease Control and Prevention
Telephone: 304-285-5951
Email: ehg8@cdc.gov
Link to Full
Announcement
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-123.html